The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Professor in neuroscience, Head of Neuroscience department
INSERM Senior Group Leader of Cellular Therapies in Brain Diseases group
Dr Charles Galea trained in the USA at the University of Utah and St. Jude Children’s Research Hospital where he extended his expertise in protein structure/function. At St. Jude he performed the first large-scale proteomics analysis of mammalian intrinsically disordered proteins. He also solved the structure of a human tumor suppressor protein p53 mutant involved in the development of adrenocortical carcinomas (featured on the cover of Protein Science). In addition to this, he showed that the intrinsic flexibility of the cell cycle regulatory protein p27 provides a molecular basis for its regulated degradation during cell division (highlighted in Nat Chem Biol)
In 2008 Dr Galea returned to Australia and joined Professor Ray Norton’s group at the Walter and Eliza Hall Institute (WEHI) (moved to the Monash Institute of Pharmaceutical Sciences (MIPS) in 2010) where his research focused on using NMR spectroscopy and other biophysical techniques to characterize peptide toxins and disease-associated human proteins. He is currently part of an international collaboration aiming to discover novel peptide toxins for the treatment of multiple sclerosis.
Dr Galea recently joined Professor Jian Li and Dr Tony Velkov’s group in Drug Delivery, Disposition and Dynamics at MIPS. His research focuses on understanding the mechanism of action of polymyxin, one of the few antibiotics currently available and still capable of successfully fighting multi-drug resistant bacteria
Leader team in the "Laboratoire de Chimie Bactérienne"
Research Director in the "Centre National de la Recherche Scientifique"
Review Editor of "Frontiers in Microbiology" specialty "Microbial Physiology and Metabolism"
MD, PhD, Associate Professor at the Faculty of Science, Department of Genetics and Evolution, University of Geneva, Switzerland. Elected Vice-Dean. Member of Academia-net. Post-doctoral stage at the ZMBH, Heidelberg, Germany; PhD in Life Sciences in Strasbourg, France; medical studies in Paris, France. Since my post-doc time, I study the molecular and cellular basis of regeneration, neurogenesis and aging and I use Hydra, a freshwater cnidarian polyp, as model system.
Professor of Biological Consevation and Management and Design of protected Áreas, Universidad Nacional de la Patagonia Austral, investigator of National Council of Scientific and Technical Research, Past President of Argentine National Parks. Recipent of the 2010 Award Leaders for the Living Planet
Professor of Molecular Microbiology and immunology at Keck School of Medicine, University of Southern California.
Professor of Ecology in the Department of Biology at Université de Sherbrooke. Associate editor of Molecular Ecology and Molecular Ecology Resources.
Professor of Vascular Pharmacology in the University of Oxford and Fellow and Tutor in Medicine, Magdalen College, Oxford. Also, a Visiting Professor at the University of Queensland, Australia. Previously, Head and Professor of Pharmacology, University of Bath (2000-2008); Reader then Professor of Cardiovascular Pharmacology, University of Bristol (1993-2000); Lecturer in Pharmacology, University of Southampton (1987-1993). Visiting Professorships in the University of Nagoya, Japan (2011), Monash University, Australia (2000-2003) and the National Academy of Sciences, Taiwan (2003).
Professor of Experimental Neuroscience, Wolfson Inst for Biomedical Research, University College London.
Biotechnologist by training, Pietro spent many years in Academia working on the understanding of the structural and functional determinants of molecular evolution processes in enzymes, protein binders and transcription Factors. Now applies these strategies in a Company's R&D department.
Head of Ecosystems and Biodiversity in the Department of Environment, Earth and Ecosystems. Director of the NERC Methane Network 'MethaneNet' . Specialises in aspects of ecosystem science and biogeochemistry relating to biosphere atmosphere exchange.
Roi Gazit, PhD. is Principal Investigator of Hematopoietic Stem Cell (HSC) transcriptome laboratory at the Ben-Gurion University of the Negev. He is a member of the National Institute for Biotechnology in the Negev (NIBN), and the Center for Regenerative Medicine and Stem Cells at BGU. Roi earned a B.Sc. and M.Sc. in life science and developmental biology from the Hebrew University of Jerusalem. He obtained PhD in immunology, under supervision of Ofer Mandelboim, studying NK-cell in vivo, including the generation of the first NK specific mouse model and elucidation of novel NK-cell abnormalities in human patients. He conducted postdoctoral studies at the Harvard Medical School, at Derrick J. Rossi laboratory, focusing on the identification and utilization of HSCs’ genes, including reprogramming of committed blood cells into HSCs using defined transcription-factors and generation of a novel HSC-reporter mouse. His laboratory at the Ben-Gurion University is studying HSCs’ transcriptome along normal development, during immune-challenges, and the direct reprogramming of adult blood cells into HSCs.